Abstract
Background and Purpose: Expression of hepatic cytochromesP450(CYP) in all species examined, including humans, is generally sexually dimorphic. We examined the sex‐dependent expression ofCYP3A5and the hormone‐regulated molecular mechanism(s) responsible for any dimorphism.Experimental Approach: CYP3A5levels as well as nuclear translocation and promoter binding of transcription factors regulatingCYP3A5expression were measured in primary hepatocyte cultures derived from men and women exposed to physiological‐like levels of growth hormone alone, dexamethasone alone and the combined regimen.Key Results: We observed a dramatic inherentCYP3A5sexual dimorphism (women > men) with all treatments as a result of a ∼2‐fold greater level of hormone‐induced activation and nuclear accumulation of hepatocyte nuclear factor‐4α (HNF‐4α), pregnane X receptor (PXR) and retinoic X receptorα (RXRα) in female hepatocytes. Furthermore,PXR : RXRα exhibited significantly higherDNAbinding levels to its specific binding motif on theCYP3A5 promoter in female hepatocytes, inferring a possible explanation for the elevated expression of the isoform in women. Results from experiments usingHepG2cells treated withsiRNA‐induced knockdown ofHNF‐4α and/or transfected with luciferase reporter constructs containing theCYP3A5promoter were in agreement with the basic mechanism observed in primary hepatocytes of both sexes.Conclusions and Implications: Female‐predominant expression of humanCYP3A5is due to an inherent, sex‐dependent suboptimal activation of the transcription networks responsible for hormone‐induced expression of the isoform in men. Accordingly, in conjunction with previous studies of other humanCYPs, men and women are intrinsically unlikely to handle many drugs in the same way; thus, sex should be a requisite component factored into the design of personalized drug therapies.

This publication has 67 references indexed in Scilit: